Literature DB >> 26255786

Additional Prognostic Value of EAS index in predicting the occurrence of rehospitalizations in chronic heart failure: data from the Daunia Heart Failure Registry.

Michele Correale1, Antonio Totaro1, Armando Ferraretti1, Francesco Musaico1, Tommaso Passero1, Fiorella De Rosa1, Silvia Abruzzese1, Riccardo Ieva1, Matteo Di Biase1, Natale Daniele Brunetti1.   

Abstract

BACKGROUND: Tissue Doppler imaging (TDI) may be useful in identifying subjects at higher risk among patients with chronic heart failure (CHF). The clinical role of newly developed TDI parameters, however, still needs to be documented.
METHODS: A total of 287 consecutive patients with CHF enrolled in the Daunia Heart Failure Registry underwent echocardiography assessment and were followed prospectively for a median 255 (204-316) days. Conventional echocardiography and TDI parameters were calculated. We also quantified by TDI a combined index (EAS index) of diastolic and systolic performance E'/(A'xS') and assessed its possible additional prognostic role in combination with 'traditional' parameters such as left ventricular ejection fraction (LVEF) and myocardial performance index (MPI).
RESULTS: Subjects readmitted for worsening HF were characterized by higher levels of EAS index (median 0·14 (95% C.I. 0·12-0·21) vs. 0·11 (0·10-0·12, P < 0·05)). Increased rates of rehospitalization were found in subjects with EAS index >median (0·115) (21% vs. 10%, P < 0·05); higher EAS index values predicted the incidence of readmissions for worsening HF during follow-up, even at multivariable analysis. The assessment of EAS index in addition to LVEF and MPI showed an adjunctive prognostic value (log-rank P < 0·001 and P < 0·05, respectively).
CONCLUSIONS: EAS index assessed by TDI may be helpful in predicting the risk of rehospitalizations in subjects with CHF. EAS index may represent an independent adjunctive tool for the risk stratification of patients with CHF in addition to 'traditional' tools such as LVEF or MPI.
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Chronic Heart Failure; EAS index; echocardiography; prognosis; tissue doppler imaging

Mesh:

Year:  2015        PMID: 26255786     DOI: 10.1111/eci.12514

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

1.  Predictors of right ventricular function improvement with sacubitril/valsartan in a real-life population of patients with chronic heart failure.

Authors:  Michele Correale; Pietro Mazzeo; Michele Magnesa; Martino Fortunato; Lucia Tricarico; Alessandra Leopizzi; Adriana Mallardi; Raffaele Mennella; Salvatore Tucci; Natale Daniele Brunetti
Journal:  Clin Physiol Funct Imaging       Date:  2021-09-28       Impact factor: 2.121

2.  Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry.

Authors:  Michele Correale; Ilenia Monaco; Armando Ferraretti; Lucia Tricarico; Giuseppina Padovano; Ennio Sascia Formica; Valeria Tozzi; Davide Grazioli; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Int J Cardiol Heart Vasc       Date:  2019-01-11

3.  Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry.

Authors:  Michele Correale; Adriana Mallardi; Pietro Mazzeo; Lucia Tricarico; Claudia Diella; Valentina Romano; Armando Ferraretti; Alessandra Leopizzi; Giuseppina Merolla; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Int J Cardiol Heart Vasc       Date:  2020-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.